Editor in Chief: María José Soler Romeo - No 218, February 2021
Let´s debate on Twitter!
Should old and multimorbid patients be dialyzed?
Many nephrologists are hesitant about putting geriatric kidney patients with comorbidities on dialysis. Fresh data from the ERA-EDTA Registry, published in NDT, showed that the impact of comorbidities (such as diabetes, ischaemic heart disease, chronic heart failure, cerebrovascular disease, peripheral vascular disease and malignancy) on survival in patients >80 years at onset of renal replacement therapy is lower than in young patients. Surprised? Will this insight change your clinical practice? If so, why? If not, why not?
Share your opinion with us on Twitter! @ERAEDTA
Dr. Maria José Soler Romeo, why should dialysis patients be in the first priority group for COVID-19 vaccination?
Read the interview
Publications you should not miss!
First do no harm? Clinical implications of removing race from estimates of kidney function
Removing race from eGFR assessment may increase the prevalence of chronic kidney disease (CKD), and the number of Black patients eligible for enhanced kidney care and wait-listing for transplantation. At the same time more Black adults would be excluded from living kidney donation and there would be more drug contraindications or dose reductions for people reclassified to advanced CKD. [Read more]
Stopping RAAS Inhibitors in advanced CKD: a balance of risks
Stopping renin-angiotensin-aldosterone system (RAAS) inhibition in people with advanced chronic kidney disease (CKD) is associated with a higher five-year absolute risk of mortality and major adverse cardiovascular events. At the same time, withdrawing RAASi is associated with a lower absolute risk of initiating kidney replacement therapy (KRT) in these patients. [Read more]
A sad SONG: dialysis patients’ perspectives on mental health
According to the global Standardized Outcomes in Nephrology (SONG) initiative, dialysis patients and their family caregivers experience mental and emotional distress as a result of the burden of hemodialysis and peritoneal dialysis, lifestyle restrictions, the constant threat of death and symptom burden, which can impair motivation for self-management. The SONG researchers recommend more attention to monitoring and management of mental health in these patients. [Read more]
An extra week of treatment does not improve outcomes in PD-related peritonitis
Extending antibiotic therapy for one extra week beyond the International Society for Peritoneal Dialysis (ISPD) guidelines should not be recommended for patients with PD-related peritonitis, according to a prospective randomized controlled trial. Extended treatment did not reduce the risk of relapsing or recurrent peritonitis episodes and was associated with a higher risk of repeat peritonitis episodes. [Read more]
58th ERA-EDTA Congress 2021
Nephrology News Flash is the official ERA-EDTA E-Newsletter
The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA in compliance with the EU General Data Protection Regulation (2016/679).
© 2021 ERA-EDTA